Cue Biopharma, Inc. (CUE) Financials
CUE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 68.9 million | 26.2 million |
2023-06-30 | 73.2 million | 27.2 million |
2023-03-31 | 81.7 million | 26.7 million |
2022-12-31 | 91.3 million | 25.6 million |
CUE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -7.8 million | 2.1 million |
2023-06-30 | -10.4 million | 2.0 million |
2023-03-31 | -10.8 million | 2.0 million |
2022-12-31 | -10.5 million | 2.1 million |
CUE Net Income
No data available :(
CUE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 54.7 million | - | 7.3 million |
2023-06-30 | 57.9 million | 6.1 million | 8.0 million |
2023-03-31 | 66.2 million | 7.1 million | 8.7 million |
2022-12-31 | 76.3 million | 8.0 million | 9.3 million |
CUE Shares Outstanding
CUE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 9.9 million | 3.6 million | - |
2023-06-30 | - | 10.7 million | 4.2 million | - |
2023-03-31 | 2000 | 9.4 million | 4.2 million | - |
2022-12-31 | 746 | 11.3 million | 3.7 million | - |
CUE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 2.1 million | 857000 |
2023-06-30 | 1.4 million | 848000 |
2023-03-31 | 187000 | 880000 |
2022-12-31 | 151227 | 580055 |
CUE
Price: $2.13
52 week price:
Earnings Per Share: -1.11 USD
P/E Ratio: -1.89
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 255300
Market Capitalization: 85.1 million